Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048171HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004651HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004652HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30002798HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007200HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007201HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007202HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075419HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075420HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075421HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB05013
Drug NameIngenol mebutate
Target IDBE0001132
UniProt IDP17252
Regulation Typeligand
PubMed IDs15126366
CitationsKedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM: Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004 May 1;64(9):3243-55.
GroupsApproved
Direct ClassificationTigliane and ingenane diterpenoids
SMILES[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C
Pathways
PharmGKB
ChEMBLCHEMBL1863513